Transcriptional profiling of cisplatin-resistant cells showed highly significant upregulation of genes normally repressed by polycomb repressive complex 2 (PRC2), associated with a decrease in the expression of BMI1 and EZH2.
← all excerpts
Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients.
1
—
—